Utsugi T, Yoon J W, Park B J, Imamura M, Averill N, Kawazu S, Santamaria P
Department of Microbiology and Infectious Diseases, Faculty of Medicine, University of Calgary, Alberta, Canada.
Diabetes. 1996 Aug;45(8):1121-31. doi: 10.2337/diab.45.8.1121.
NOD mouse-derived beta-cell-specific cytotoxic T-cell (beta-CTL) clones are diabetogenic in adult NOD mice, but only if co-injected with splenic CD4+ T-cells from diabetic animals. This investigation was initiated to determine whether infiltration of pancreatic islets by beta-CTL is a major histocompatibility complex (MHC) class I-restricted response, and whether beta-CTL has a direct cytopathic effect on beta-cells in vivo. Pancreatic islets from BALB/c (H-2d) or B6 (H-2b) mice were transplanted under the renal capsule of streptozotocin (STZ)-induced diabetic (NOD x BALB/c) F1 (H-2Kd, H-2Dd,b) or NOD x B6) F1 (H-2Kd,b, H-2Db) mice, respectively. H-2Kd-restricted beta-CTL clones from NOD mice were transfused into euglycemic mice within 3 days after transplantation. In all of the H-2d islet-grafted (NOD x BALB/c) F1 mice that received the beta-CTL clones, the beta-CTLs homed into the grafts, recruited host Mac-1+ cells and CD4+ and CD8+ T-cells, and caused diabetes within 7 days. In contrast, none of the H-2b islet-grafted (NOD x B6) F1 mice who received the beta-CTL clones and none of the H-2d islet-grafted (NOD x BALB/c) F1 mice who received a non-beta-cell cytotoxic CTL clone (N beta-CTL) developed graft inflammation or diabetes. Depletion of CD4+ T-cells in H-2d islet-grafted (NOD x BALB/c) F1 mice did not prevent beta-CTL clone-induced diabetes but reduced its severity. In contrast, when the beta-CTL clones were injected > 8 days after transplantation, none of the H-2d islet-grafted (NOD x BALB/c) F1 mice became diabetic or developed graft inflammation. We conclude that (1) islet-derived beta-CTLs can destroy beta-cells in vivo; (2) infiltration of grafted islets by beta-CTLs is an MHC class I-restricted response; (3) beta-CTLs can recruit naive CD4+ T-cells to the site, leading to further beta-cell damage; and (4) revascularized islet grafts are, like pancreatic islets of irradiated adult NOD mice, "sequestered" from circulating beta-CTLs.
源自非肥胖糖尿病(NOD)小鼠的β细胞特异性细胞毒性T细胞(β-CTL)克隆在成年NOD小鼠中具有致糖尿病作用,但前提是要与糖尿病动物的脾脏CD4 + T细胞共同注射。启动这项研究是为了确定β-CTL对胰岛的浸润是否是主要组织相容性复合体(MHC)I类限制性反应,以及β-CTL在体内是否对β细胞具有直接的细胞病变作用。将来自BALB/c(H-2d)或B6(H-2b)小鼠的胰岛分别移植到链脲佐菌素(STZ)诱导的糖尿病(NOD×BALB/c)F1(H-2Kd,H-2Dd,b)或NOD×B6)F1(H-2Kd,b,H-2Db)小鼠的肾被膜下。在移植后3天内,将来自NOD小鼠的H-2Kd限制性β-CTL克隆输注到血糖正常的小鼠体内。在所有接受β-CTL克隆的H-2d胰岛移植(NOD×BALB/c)F1小鼠中,β-CTL归巢到移植物中,募集宿主Mac-1 +细胞以及CD4 +和CD8 + T细胞,并在7天内导致糖尿病。相比之下,接受β-CTL克隆的H-2b胰岛移植(NOD×B6)F1小鼠以及接受非β细胞细胞毒性CTL克隆(Nβ-CTL)的H-2d胰岛移植(NOD×BALB/c)F1小鼠均未发生移植物炎症或糖尿病。在H-2d胰岛移植(NOD×BALB/c)F1小鼠中耗尽CD4 + T细胞并不能预防β-CTL克隆诱导的糖尿病,但会降低其严重程度。相反,当在移植后> 8天注射β-CTL克隆时,没有一只H-2d胰岛移植(NOD×BALB/c)F1小鼠发生糖尿病或移植物炎症。我们得出以下结论:(1)胰岛来源的β-CTL可以在体内破坏β细胞;(2)β-CTL对移植胰岛的浸润是MHC I类限制性反应;(3)β-CTL可以将幼稚的CD4 + T细胞募集到该部位,导致进一步的β细胞损伤;(4)血管化的胰岛移植物与经辐照的成年NOD小鼠的胰岛一样,对循环中的β-CTL“隔离”。